Significant fluctuations in blood sugar levels can damage blood vessels in the retina if not well-controlled, potentially leading to serious vision problems and even blindness if left untreated
Ultimately, the best weight loss solution is one that is safe, effective, and customized for you
Across STEP 1 and 3 trials involving non-diabetic participants, semaglutide 2.4 mg exhibited average placebo-adjusted weight reductions of 12.4% and 10.3%, respectively, by week 68
Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities
Your healthcare team can discuss the most appropriate medication based on your individual circumstances and medical history
Retatrutide Regulatory Status As of June 2026, retatrutide is not approved by the FDA, the EMA, or any other regulatory agency